Literature DB >> 30678861

Paracrine Regulation of Aldosterone Secretion in Physiological and Pathophysiological Conditions.

Hervé Lefebvre1, Céline Duparc2, Alexandre Naccache3, Antoine-Guy Lopez4, Mireille Castanet3, Estelle Louiset2.   

Abstract

Aldosterone secretion by the zona glomerulosa of the adrenal cortex is controlled by circulating factors including the renin angiotensin system (RAS) and potassium. Mineralocorticoid production is also regulated through an autocrine/paracrine mechanism by a wide variety of bioactive signals released in the vicinity of adrenocortical cells by chromaffin cells, nerve endings, cells of the immune system, endothelial cells and adipocytes. These regulatory factors include conventional neurotransmitters and neuropeptides. Their physiological role in the control of aldosterone secretion is not fully understood, but it is likely that they participate in the RAS-independent regulation of zona glomerulosa cells. Interestingly, recent observations indicate that autocrine/paracrine processes are involved in the pathophysiology of primary aldosteronism. The intraadrenal regulatory systems observed in aldosterone-producing adenomas (APA), although globally similar to those occurring in the normal adrenal gland, harbor alterations at different levels, which tend to strengthen the potency of paracrine signals to activate aldosterone secretion. Enhancement of paracrine stimulatory tone may participate to APA expansion and aldosterone hypersecretion together with somatic mutations of driver genes which activate the calcium signaling pathway and subsequently aldosterone synthase expression. Intraadrenal regulatory mechanisms represent thus promising pharmacological targets for the treatment of primary aldosteronism.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenal; Mast cell; Mutations; Paracrine communication; Primary aldosteronism; Serotonin; Steroidogenesis

Mesh:

Substances:

Year:  2018        PMID: 30678861     DOI: 10.1016/bs.vh.2018.10.001

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  4 in total

1.  Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs.

Authors:  Darcy Adin; Clarke Atkins; Gabrielle Wallace; Allison Klein
Journal:  J Vet Intern Med       Date:  2021-03-13       Impact factor: 3.333

Review 2.  Anticipated pharmacological role of Aviptadil on COVID-19.

Authors:  Tuhin Mukherjee; Tapan Behl; Sanchay Sharma; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Bijo Mathew; Jasleen Kaur; Ratandeep Kaur; Mayukh Das; Lotfi Aleya; Simona Bungau
Journal:  Environ Sci Pollut Res Int       Date:  2021-11-30       Impact factor: 5.190

Review 3.  Sexual Dimorphism of Corticosteroid Signaling during Kidney Development.

Authors:  Margaux Laulhé; Laurence Dumeige; Thi An Vu; Imene Hani; Eric Pussard; Marc Lombès; Say Viengchareun; Laetitia Martinerie
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

4.  Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.

Authors:  Darcy Adin; Clarke Atkins; Oliver Domenig; Teresa DeFrancesco; Bruce Keene; Sandra Tou; Joshua A Stern; Kathryn M Meurs
Journal:  J Vet Intern Med       Date:  2020-02-29       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.